Skip to main content
TipRanks
Go Ultimate75% OFF
Altesa BioSciences logo

Altesa BioSciences: Valuation, Funding & Investors

Atlanta, GA, UShttps://www.altesa.com/Therapeutics

A clinical-stage pharmaceutical company focused on developing therapies for chronic lung diseases, including COPD and asthma. The company is advancing novel antiviral and respiratory treatments aimed at reducing respiratory exacerbations and improving patient outcomes.

Leadership & Board

Current Number of Employees
21
Current LinkedIn Followers
2,310

Latest Estimated Valuation

Total Amount Raised
$75M
Total Funding Rounds
1
Latest Funding Amount
$75M
Latest Funding Round
Series B

Employee Trend

Altesa BioSciences had 21 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

21Latest Employee Count
0(0.00%)Week-Over-Week Change
010203040Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Altesa BioSciences had 2,310 followers as of November 16, 2026. The number of followers increased by 5 (0.22%) week-over-week.

2,310Latest Followers Count
5(0.22%)Week-Over-Week Change
01,0002,0003,0004,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Feb 19, 2026Series B$75.00M―

Investors

Investor NameFunding Round
Atlantic PartnersSeries B
ForbionSeries B
MedicxiSeries B
PitangoSeries B
SanofiSeries B

Similar Companies

A snapshot of private companies similar to Altesa BioSciences, helping you discover and navigate related company profiles.

Related News and Analysis